Name
Biolaborid OÜ
Registry code
11879691
VAT number
EE101497871
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
18.01.2010 (14)
Financial year
01.01-31.12
Capital
115 001.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Cellin Technologies 11543666 | 72% - 82 511.00 EUR | - | - | |
| MEDCO PARTNERS OSAÜHING 10860152 | 1% - 745.00 EUR | - | - | |
| AS Taastava Kirurgia Kliinik 10286204 | 28% - 31 745.00 EUR | - | - | |
| Ivar Järving 13.07.1957 (67) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Andrus Loog 14.08.1963 (61) | - | - | Member of a higher management body, i.e. board member or supervisory board member | Chairman of the board |
| Tiit Meren 21.06.1955 (69) | - | - | Indirect ownership | |
| Ivari Saar 04.05.1985 (39) | - | - | - | Board member |
| Osaühing ProtoBioS 10981915 | - | - | - | Founder |
| 2019 30.10.2020 | 2020 10.05.2022 | 2021 06.06.2022 | 2022 18.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 108 000 € | 108 000 € | 108 000 € | 108 000 € |
| Net profit (loss) for the period | 19 764 € | 25 847 € | 22 916 € | -46 526 € |
| Profit Margin | 18% | 24% | 21% | -43% |
| Current Assets | 170 485 € | 233 766 € | 321 677 € | 313 081 € |
| Fixed Assets | 309 613 € | 276 418 € | 277 111 € | 245 100 € |
| Total Assets | 480 098 € | 510 184 € | 598 788 € | 558 181 € |
| Current Liabilities | 391 440 € | 389 680 € | 404 402 € | 410 321 € |
| Non Current Liabilities | 4 500 € | 4 500 € | 20 266 € | 20 266 € |
| Total Liabilities | 395 940 € | 394 180 € | 424 668 € | 430 587 € |
| Share Capital | - | - | - | - |
| Equity | 84 158 € | 116 004 € | 174 120 € | 127 594 € |
| Employees | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 1 030.62 € | 1 060.62 € | 1 |
| 2023 Q4 | - | 1 009.61 € | 1 027.87 € | 2 |
| 2023 Q3 | 318 000 € | 55 550.88 € | 1 099.17 € | 2 |
| 2023 Q2 | 27 000 € | 3 340.78 € | 1 760.3 € | 2 |
| 2023 Q1 | 27 000 € | 2 851.42 € | 1 760.3 € | 2 |
| 2022 Q4 | 27 000 € | 5 906.28 € | 1 331.54 € | 2 |
| 2022 Q3 | 27 000 € | 4 840.62 € | 1 602.46 € | 2 |
| 2022 Q2 | 27 000 € | 4 815.18 € | 606.2 € | 2 |
| 2022 Q1 | 27 000 € | 4 883.39 € | 872.32 € | - |
| 2021 Q4 | 27 000 € | 9 191 € | 1 239.32 € | 2 |
| 2021 Q3 | 27 000 € | 8 578.9 € | 3 306.68 € | 2 |
| 2021 Q2 | 27 000 € | 2 535.6 € | 541.84 € | 2 |
| 2021 Q1 | 27 000 € | 5 176.58 € | - | 2 |
| 2020 Q4 | 27 000 € | 5 844.83 € | 868.46 € | 2 |
| 2020 Q3 | 27 000 € | 5 906.93 € | 868.46 € | 2 |
| 2020 Q2 | 27 000 € | 2 427.51 € | 2.88 € | 2 |
| 2020 Q1 | 27 000 € | 4 591.18 € | 1 433.96 € | 2 |
